Prof. Dr. med. Florian Leuschner
Project Leader A07
Heidelberg University
Medical Faculty Heidelberg
University Hospital Heidelberg
Department of Internal Medicine III
Im Neuenheimer Feld 410
D-69120 Heidelberg
florian.leuschner@med.uni-heidelberg.de

Professional Career
2020
Specialist for Heart Failure
DGK certification
since 2018
Heisenberg Professorship “Immunocardiology”
Heidelberg University
since 2018
Head of Interventional Valve Replacement (TAVI)
University Hospital Heidelberg
since 2018
Head of the interdisciplinary “Carditis-Team”
University Hospital Heidelberg
2017
Medical Specialist for Interventional Cardiology
DGK certification
2015
Medical Specialist for Cardiology
University Hospital Heidelberg
2015
Habilitation (Venia legendi) for Internal Medicine
Supervisor: Prof. H. Katus, Heidelberg University
since 2014
Senior Physician
University Hospital Heidelberg
2013
Medical Specialist for Internal Medicine
University Hospital Heidelberg
since 2012
Research Group Leader
University Hospital Heidelberg
2009 - 2012
Postdoctoral Fellow
Supervisor: Prof. Matthias Nahrendorf, Massachusetts General Hospital/, Harvard Medical School, USA
2005
Doctor of Medicine
Supervisor: Prof. Vinzenz Hombach, University of Ulm
Achievements & Awards
2021-2026
European Coordinator
Leducq Network “The Inflammatory-Fibrosis Axis in Ischemic Heart Failure
since 2019
Member
Walter Siegenthaler Society
since 2018
Member
Editorial Board Basic Research in Cardiology
since 2017
Member
Confirm Consortium (BMBF)
2016
Science Award
Walter Siegenthaler Society
2015-2018
Member and Speaker
Junior Research Group of the Federal Ministry of Education and Research (BMBF, DeCaRe Consortium=
2015
Publication Award
German Cardiac Society (working group 10)
since 2013
Member/ Principal Investigator
German Centre for Cardiovascular Research (DZHK, Partner Site HD/MA)
2011
Stipend
German Academic Exchange Service (DAAD)
2009
Postdoctoral Fellowship
German Heart Research Foundation
2009
Klaus-Tschira Scholarship
Klaus-Tschira Foundation
Publications
Blockade of Wnt Secretion Attenuates Myocardial Ischemia-Reperfusion Injury by Modulating the Inflammatory Response
A Minimal-Invasive Approach for Standardized Induction of Myocardial Infarction in Mice
Circ Res. 2020 Oct 9;127(9):1214-1216. doi: 10.1161/CIRCRESAHA.120.317794. Epub 2020 Aug 28. PMID: 32854590
Learn moreSecretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction
Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction
Eur Heart J. 2020 Mar 1;41(9):989-994. doi: 10.1093/eurheartj/ehz159. PMID: 30945736
Learn moreThe role of Wnt signaling in the healing myocardium: a focus on cell specificity
Basic Res Cardiol. 2018 Oct 16;113(6):44. doi: 10.1007/s00395-018-0705-y. PMID: 30327885
Learn moreSilencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis
Front Immunol. 2018 Oct 8;9:2303. doi: 10.3389/fimmu.2018.02303. eCollection 2018. PMID: 30349538
Learn moreThe cardiac microenvironment uses non-canonical WNT signaling to activate monocytes after myocardial infarction
EMBO Mol Med. 2017 Sep;9(9):1279-1293. doi: 10.15252/emmm.201707565. PMID: 28774883
Learn moreSilencing of CCR2 in myocarditis
Eur Heart J. 2015 Jun 14;36(23):1478-88. doi: 10.1093/eurheartj/ehu225. Epub 2014 Jun 20. PMID: 24950695
Learn moreRapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis
J Exp Med. 2012 Jan 16;209(1):123-37. doi: 10.1084/jem.20111009. Epub 2012 Jan 2. PMID: 22213805
Learn moreTherapeutic siRNA silencing in inflammatory monocytes in mice
Nat Biotechnol. 2011 Oct 9;29(11):1005-10. doi: 10.1038/nbt.1989. PMID: 21983520
Learn more